Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non-diabetic and diabetic patients

Clinical and Experimental Ophthalmology

Volumn 34, Issue 6, 2006, Pages 526-534

  Elgohary, Mostafa A ^a,b   Dowler, Jonathan G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

Capsulotomy; Cataract; Diabetes mellitus; Incidence; Intraocular; Lens; Nd:YAG; Phacoemulsification

Indexed keywords

POLY(METHYL METHACRYLATE); SILICONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAPSULOTOMY; CATARACT; CILIARY DISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEODYMIUM LASER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PHACOEMULSIFICATION; POSTOPERATIVE INFLAMMATION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SILICONE PROSTHESIS; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CATARACT; DIABETES COMPLICATIONS; FEMALE; HUMANS; INCIDENCE; LASER SURGERY; LENS CAPSULE, CRYSTALLINE; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33747342093     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01263.x     Document Type: Article

References (55)

1. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998; 105: 1213-21.
2. Keates RH, Steinert RF, Puliafito CA, Maxwell SK. Long-term follow-up of Nd:YAG laser posterior capsulotomy. J Am Intraocul Implant Soc 1984; 10: 164-8.
3. Baratz KH, Cook BE, Hodge DO. Probability of Nd:YAG laser capsulotomy after cataract surgery in Olmsted County, Minnesota. Am J Ophthalmol 2001; 131: 161-6.
4. Ando H, Ando N, Oshika T. Cumulative probability of neodymium:YAG laser posterior capsulotomy after phacoemulsification. J Cataract Refract Surg 2003; 29: 2148-54.
5. Ionides A, Dowler JG, Hykin PG, Rosen PH, Hamilton AM. Posterior capsule opacification following diabetic extracapsular cataract extraction. Eye 1994; 8: 535-7.
6. Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol 2002; 134: 10-16.
7. Zaczek A, Zetterstrom C. Posterior capsule opacification after phacoemulsification in patients with diabetes mellitus. J Cataract Refract Surg 1999; 25: 233-7.
8. Knorz MC, Soltau JB, Seiberth V, Lorger C. Incidence of posterior capsule opacification after extracapsular cataract extraction in diabetic patients. Metab Pediatr Syst Ophthalmol 1991; 14: 57-8.
9. Hollick EJ, Spalton DJ, Ursell PG, Pande MV. Lens epithelial cell regression on the posterior capsule with different intraocular lens materials. Br J Ophthalmol 1998; 82: 1182-8.
10. Meacock WR, Spalton DJ, Hollick EJ, Barman S, Boyce JF. The effect of polymethylmethacrylate and acrysof intraocular lenses on the posterior capsule in patients with a large capsulorrhexis. Jpn J Ophthalmol 2001; 45: 348-54.
11. Findl O, Neumayer T, Buehl W, Sacu S. Short-term changes in the morphology of posterior capsule opacification [Abstract]. Book of Abstracts: XXII Congress of the ESCRS 2004; 29.
12. Ingram RM, Banerjee D, Traynar MJ, Thompson RK. Day-case cataract surgery. Trans Ophthalmol Soc UK 1980; 100: 205-9.
13. Ursell PG, Spalton DJ, Panda MV et al. Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 1998; 24: 352-60.
14. Hollick EJ, Spalton DJ, Ursell PG et al. The effect of polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3 years after cataract surgery. Ophthalmology 1999; 106: 49-54.
15. Kato K, Kurosaka D, Nagamoto T. Apoptotic cell death in rabbit lens after lens extraction. Invest Ophthalmol Vis Sci 1997; 38: 2322-30.
16. Saika S, Miyamoto T, Ishida I, Ohnishi Y, Ooshima A. Lens epithelial cell death after cataract surgery. J Cataract Refract Surg 2002; 28: 1452-6.
17. Liao SB, Ku WC. Progression of diabetic retinopathy after phacoemulsification in diabetic patients: A three-year analysis. Chang Gung Med J 2003; 26: 829-34.
18. Hauser D, Katz H, Pokroy R, Bukelman A, Shectman E, Pollack A. Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery. J Cataract Refract Surg 2004; 30: 428-32.
19. Saitoh J, Nishi O, Hitani H. Cell density and hexagonality of lens epithelium in human cataracts [Abstract]. Nippon Ganka Gakkai Zasshi 1990; 94: 176-80.
20. Struck HG, Heider C, Lautenschlager C. Changes in the lens epithelium of diabetic and non-diabetic patients with various forms of opacities in senile cataract [Abstract]. Klin Monatsbl Augenheilkd 2000; 216: 204-9.
21. Kinoshita JH. Mechanisms initiating cataract formation. Proctor lecture. Invest Ophthalmol 1974; 13: 713-24.
22. Lin LR, Reddy VN, Giblin FJ, Kador PF, Kinoshita JH. Polyol accumulation in cultured human lens epithelial cells. Exp Eye Res 1991; 52: 93-100.
23. Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Apoptotic cell death in the lens epithelium of rat sugar cataract. Exp Eye Res 2003; 77: 51-7.
24. Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J 2003; 17: 315-17.
25. Hothersall JS, Taylaur CE, McLean P. Antioxidant status in an in vitro model for hyperglycemic lens cataract formation: Effect of aldose reductase inhibitor statil. Biochem Med Metab Biol 1988; 40: 109-17.
26. Kubo E, Urakami T, Fatma N, Akagi Y, Singh DP. Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: Role of AOP2. Biochem Biophys Res Commun 2004; 314: 1050-6.
27. Liu CS, Wormstone IM, Duncan G, Marcantonio JM, Webb SF, Davies PD. A study of human lens cell growth in vitro. A model for posterior capsule opacification. Invest Ophthalmol Vis Sci 1996; 37: 906-14.
28. Wormstone IM, Liu CS, Rakic JM, Marcantonio JM, Vrensen GF, Duncan G. Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci 1997; 38: 396-404.
29. Hayashi H, Hayashi K, Nakao F, Hayashi F. Quantitative comparison of posterior capsule opacification after polymethylmethacrylate, silicone, and soft acrylic intraocular lens implantation. Arch Ophthalmol 1998; 116: 1579-82.
30. Olson RJ, Crandall AS. Silicone versus polymethylmethacrylate intraocular lenses with regard to capsular opacification. Ophthalmic Surg Lasers 1998; 29: 55-8.
31. Apple DJ, Peng Q, Vis ssook N et al. Eradication of posterior capsule opacification: Documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. Ophthalmology 2001; 108: 505-18.
32. Mamalis N, Phillips B, Kopp CH, Crandall AS, Olson RJ. Neodymium:YAG capsulotomy rates after phacoemulsification with silicone posterior chamber intraocular lenses. J Cataract Refract Surg 1996; 22 (Suppl. 2): 1296-302.
33. Cumming JS. Postoperative complications and uncorrected acuities after implantation of plate haptic silicone and three-piece silicone intraocular lenses. J Cataract Refract Surg 1993; 19: 263-74.
34. Schmidbauer JM, Vargas LG, Peng Q et al. Posterior capsule opacification. Int Ophthalmol Clin 2001; 41: 109-31.
35. Nishi O, Nishi K. Disruption of the blood-aqueous barrier by residual lens epithelial cells after intraocular lens implantation. Ophthalmic Surg 1992; 23: 325-9.
36. Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992; 76: 338-41.
37. Nishi O, Nishi K, Wada K, Ohmoto Y. Expression of transforming growth factor (TGF)-alpha, TGF-beta(2) and interleukin 8 messenger RNA in postsurgical and cultured lens epithelial cells obtained from patients with senile cataracts. Graefes Arch Clin Exp Ophthalmol 1999; 237: 806-11.
38. Quinlan M, Wormstone IM, Duncan G, Davies PD. Phacoemulsification versus extracapsular cataract extraction: A comparative study of cell survival and growth on the human capsular bag in vitro. Br J Ophthalmol 1997; 81: 907-10.
39. Davidson MG, Wormstone M, Morgan D, Malakof R, Allen J, McGahan MC. Ex vivo canine lens capsular sac explants. Graefes Arch Clin Exp Ophthalmol 2000; 238: 708-14.
40. Wallentin N, Wickstrom K, Lundberg C. Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 1998; 39: 1410-18.
41. Wormstone IM, Tamiya S, Anderson I, Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002; 43: 2301-8.
42. de Boer JH, Limpens J, Orengo-Nania S, de Jong PT, La Heij E, Kijlstra A. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci 1994; 35: 3702-10.
43. Oshika T, Tsuboi S, Yaguchi S et al. Comparative study of intraocular lens implantation through 3.2- and 5.5-mm incisions. Ophthalmology 1994; 101: 1183-90.
44. Oshika T, Nagahara K, Yaguchi S et al. Three year prospective, randomized evaluation of intraocular lens implantation through 3.2 and 5.5 mm incisions. J Cataract Refract Surg 1998; 24: 509-14.
45. Pande MV, Spalton DJ, Kerr-Muir MG, Marshall J. Postoperative inflammatory response to phacoemulsification and extracapsular cataract surgery: Aqueous flare and cells. J Cataract Refract Surg 1996; 22 (Suppl. 1): 770-4.
46. Mansfield KJ, Cerra A, Chamberlain CG. Effects of dexamethasone on posterior capsule opacification-like changes in a rat lens explant model. Mol Vis 2004; 10: 728-37.
47. Cortina P, Gomez-Lechon MJ, Navea A, Menezo JL, Terencio MC, Diaz-Llopis M. Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture. Graefes Arch Clin Exp Ophthalmol 1997; 235: 180-5.
48. Helbig H, Kellner U, Bornfeld N, Foerster MH. Cataract surgery and YAG-laser capsulotomy following vitrectomy for diabetic retinopathy. Ger J Ophthalmol 1996; 5: 408-14.
49. Pinter SM, Sugar A. Phacoemulsification in eyes with past pars plana vitrectomy: Case-control study. J Cataract Refract Surg 1999; 25: 556-61.
50. Grusha YO, Masket S, Miller KM. Phacoemulsification and lens implantation after pars plana vitrectomy. Ophthalmology 1998; 105: 287-94.
51. Chang MA, Parides MK, Chang S, Braunstein RE. Outcome of phacoemulsification after pars plana vitrectomy. Ophthalmology 2002; 109: 948-54.
52. Jacob TJ, Humphry RC, Davies EG, Thompson GM. Human retinal extract stimulates the proliferation of human lens epithelial cells. Eye 1988; 2: 304-8.
53. Jones NP, McLeod D, Boulton ME. Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy. Br J Ophthalmol 1995; 79: 261-3.
54. Hales AM, Chamberlain CG, Murphy CR, McAvoy JW. Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta). J Exp Med 1997; 185: 273-80.
55. Chen Z, John M, Subramanian S, Chen H, Carper D. 17Beta-estradiol confers a protective effect against transforming growth factor-beta2-induced cataracts in female but not male lenses. Exp Eye Res 2004; 78: 67-74.